OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 12/06/2024
Week ended 12/06/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 12/06/2024
- The Week’s Most Important Closed M&A Transactions:
- On December 6, 2024, Organigram (OGI: TSX) completed its acquisition of Motif Labs (Private), a Canadian leader in the vape and infused pre-roll categories with a portfolio of strong brands, including BOXHOT.
- The acquisition creates a company with the #1 market share in Canadian recreational cannabis.
- Consideration of $71.28M includes $28.51M of stock, $35.64M in cash, and $7.13M in earnouts.
- The transaction values Motif at 1.06x LTM revenues and 19.4X LTM EBITDA.
- Organigram believes synergies of up to $10M can be achieved in the combination.
Week ended 12/06/2024
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.